Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ann Thor

Concepts (434)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
64
2022
1781
4.440
 Why?
Receptor, ErbB-2
24
2018
301
3.010
 Why?
Metformin
10
2018
283
2.460
 Why?
Tamoxifen
10
2020
187
1.720
 Why?
Receptors, Estrogen
15
2020
368
1.610
 Why?
Receptor, ErbB-3
8
2016
42
1.500
 Why?
Cell Proliferation
15
2018
2158
1.320
 Why?
Genes, erbB-2
8
2013
24
1.270
 Why?
Mammary Neoplasms, Experimental
6
2017
61
1.210
 Why?
Apoptosis
20
2018
2319
0.900
 Why?
Cell Line, Tumor
22
2020
2669
0.840
 Why?
Thyroid Hormones
1
2020
54
0.780
 Why?
Hormone Replacement Therapy
1
2020
75
0.760
 Why?
Up-Regulation
3
2020
793
0.760
 Why?
Triple Negative Breast Neoplasms
3
2016
151
0.710
 Why?
Mammary Neoplasms, Animal
3
2018
29
0.700
 Why?
Disease-Free Survival
11
2020
633
0.670
 Why?
Tumor Suppressor Protein p53
13
2011
444
0.640
 Why?
Immunohistochemistry
24
2017
1603
0.640
 Why?
Neoplasms, Germ Cell and Embryonal
3
2023
47
0.620
 Why?
Hypoglycemic Agents
3
2017
621
0.610
 Why?
Biomarkers, Tumor
10
2021
984
0.600
 Why?
Testicular Neoplasms
3
2023
82
0.600
 Why?
Gene Expression Regulation, Neoplastic
18
2021
1114
0.600
 Why?
ErbB Receptors
4
2010
565
0.590
 Why?
Claudins
1
2016
21
0.570
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2015
1365
0.560
 Why?
Antineoplastic Agents
9
2018
1929
0.550
 Why?
Receptor, IGF Type 1
3
2016
55
0.550
 Why?
Transcriptome
1
2020
704
0.540
 Why?
Carcinogenesis
1
2016
157
0.510
 Why?
Prognosis
17
2016
3245
0.500
 Why?
Carcinoma, Ductal, Breast
5
2002
70
0.500
 Why?
Cell Cycle
4
2013
509
0.490
 Why?
Estradiol
2
2009
462
0.480
 Why?
Trastuzumab
7
2016
90
0.480
 Why?
Lymphatic Metastasis
16
2021
227
0.470
 Why?
Caspases
4
2009
259
0.470
 Why?
Genistein
2
2010
20
0.460
 Why?
Female
64
2022
58205
0.430
 Why?
Antineoplastic Agents, Hormonal
5
2020
138
0.430
 Why?
Signal Transduction
15
2018
4136
0.430
 Why?
Receptors, Steroid
1
2012
55
0.430
 Why?
Antimetabolites, Antineoplastic
1
2012
76
0.420
 Why?
Drug Resistance, Neoplasm
9
2016
671
0.400
 Why?
Neoplasm Invasiveness
7
2016
399
0.390
 Why?
STAT3 Transcription Factor
1
2012
175
0.380
 Why?
Genes, p53
5
2000
53
0.380
 Why?
Humans
81
2023
109574
0.370
 Why?
Neoplasm Proteins
5
2016
382
0.350
 Why?
Glucose
1
2013
872
0.340
 Why?
Glycoproteins
2
2005
296
0.330
 Why?
Intracellular Signaling Peptides and Proteins
2
2010
384
0.330
 Why?
Mice, Transgenic
8
2018
1591
0.320
 Why?
Mammary Tumor Virus, Mouse
2
2004
18
0.320
 Why?
MCF-7 Cells
4
2020
113
0.300
 Why?
MicroRNAs
4
2021
580
0.300
 Why?
Carcinoma
4
1995
193
0.300
 Why?
Doxorubicin
9
2011
285
0.280
 Why?
Polymerase Chain Reaction
6
2021
853
0.280
 Why?
Bromodeoxyuridine
2
1999
71
0.280
 Why?
Mice
16
2022
12565
0.270
 Why?
Protein Kinase Inhibitors
3
2016
841
0.270
 Why?
Antibodies, Monoclonal
6
2013
1052
0.270
 Why?
Animals
22
2022
29555
0.270
 Why?
Xenograft Model Antitumor Assays
3
2020
728
0.260
 Why?
Tyrosine
2
2007
185
0.260
 Why?
Radiation Tolerance
1
2005
97
0.260
 Why?
Quinazolines
2
2016
241
0.250
 Why?
Phosphorylation
5
2011
1468
0.250
 Why?
Cocarcinogenesis
1
2003
8
0.240
 Why?
Isoflavones
1
2003
22
0.240
 Why?
Cell Survival
5
2018
959
0.240
 Why?
Paclitaxel
4
2015
186
0.240
 Why?
Seminoma
1
2023
15
0.240
 Why?
Chromosomes
1
2003
73
0.230
 Why?
Multivariate Analysis
7
2005
1455
0.230
 Why?
Receptors, Progesterone
5
2012
315
0.230
 Why?
Cyclins
2
2000
69
0.220
 Why?
Chromosomes, Human, Pair 8
1
2002
34
0.220
 Why?
Chromosome Aberrations
1
2002
126
0.220
 Why?
Enzyme Activation
3
2009
711
0.210
 Why?
Ki-67 Antigen
3
2014
102
0.210
 Why?
Cyclophosphamide
7
2011
217
0.210
 Why?
Breast
4
2018
126
0.210
 Why?
Orchiectomy
1
2021
56
0.210
 Why?
Diet
3
2018
1053
0.210
 Why?
Retroperitoneal Neoplasms
1
2021
16
0.210
 Why?
Neoplasm Staging
8
2021
1105
0.200
 Why?
Obesity
4
2022
2619
0.200
 Why?
Survival Analysis
7
2005
1213
0.200
 Why?
Rats
7
2022
5346
0.200
 Why?
Neoplastic Stem Cells
2
2014
325
0.190
 Why?
Teratoma
1
2021
85
0.190
 Why?
Phosphatidylinositol 3-Kinases
3
2011
304
0.190
 Why?
TOR Serine-Threonine Kinases
3
2012
354
0.190
 Why?
Mice, SCID
1
2020
276
0.190
 Why?
Ovarian Neoplasms
4
1995
381
0.190
 Why?
Middle Aged
26
2021
26782
0.190
 Why?
Mice, Inbred NOD
1
2020
335
0.180
 Why?
Carcinoma, Papillary
1
1999
61
0.180
 Why?
Antigens, Neoplasm
2
2009
156
0.180
 Why?
Autism Spectrum Disorder
1
2023
258
0.180
 Why?
Mitotic Index
1
1999
24
0.180
 Why?
Proto-Oncogene Proteins
5
2008
593
0.180
 Why?
Chemotherapy, Adjuvant
5
2015
288
0.180
 Why?
Receptors, Androgen
2
2017
124
0.170
 Why?
Aromatase
1
2018
29
0.170
 Why?
Drug Synergism
3
2018
317
0.170
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
52
0.170
 Why?
Kaplan-Meier Estimate
1
2020
847
0.160
 Why?
HSP90 Heat-Shock Proteins
1
2018
44
0.160
 Why?
Phenylthiohydantoin
2
2017
40
0.160
 Why?
Ovariectomy
4
2022
119
0.160
 Why?
Fluorouracil
5
2009
133
0.160
 Why?
Down-Regulation
3
2010
569
0.160
 Why?
Tumor Burden
4
2022
244
0.160
 Why?
In Situ Hybridization, Fluorescence
4
2008
308
0.160
 Why?
Poly(ADP-ribose) Polymerases
2
2009
83
0.160
 Why?
Cell Division
4
2005
679
0.160
 Why?
Estrogen Receptor alpha
2
2018
117
0.150
 Why?
Organic Cation Transport Proteins
1
2017
28
0.150
 Why?
Postmenopause
5
2022
301
0.150
 Why?
Triazoles
1
2018
128
0.150
 Why?
Caspase 3
3
2006
238
0.150
 Why?
Smad Proteins
1
2016
30
0.140
 Why?
Gene Knock-In Techniques
1
2016
36
0.140
 Why?
Ovary
1
2017
202
0.140
 Why?
Calcitriol
1
2016
51
0.140
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
246
0.140
 Why?
Estrogens
1
2018
305
0.140
 Why?
Proteins
2
1992
836
0.140
 Why?
Protein Tyrosine Phosphatases
1
2016
102
0.140
 Why?
Drug Screening Assays, Antitumor
2
2016
180
0.130
 Why?
Gene Amplification
2
2009
97
0.130
 Why?
Mental Disorders
1
2023
893
0.130
 Why?
Fatty Acid Synthase, Type I
1
2014
7
0.130
 Why?
Mice, Knockout
1
2020
2224
0.130
 Why?
Disease Progression
6
2018
2212
0.130
 Why?
Immunoradiometric Assay
1
1994
1
0.130
 Why?
Cathepsin D
1
1994
7
0.130
 Why?
Antibodies, Monoclonal, Humanized
4
2013
623
0.130
 Why?
Postpartum Period
2
2014
261
0.130
 Why?
Adenocarcinoma
3
2012
661
0.130
 Why?
Immunoprecipitation
2
2011
149
0.130
 Why?
Androgen Receptor Antagonists
1
2014
31
0.120
 Why?
Tumor Cells, Cultured
5
2009
825
0.120
 Why?
Insulin-Like Growth Factor I
1
2016
276
0.120
 Why?
Transforming Growth Factor beta
1
2016
399
0.120
 Why?
Androgen Antagonists
1
2014
76
0.120
 Why?
Receptor, ErbB-4
2
2010
19
0.120
 Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2010
59
0.120
 Why?
Disease Models, Animal
4
2017
3439
0.110
 Why?
Blotting, Western
3
2011
1135
0.110
 Why?
Nucleic Acid Hybridization
2
2003
148
0.110
 Why?
Vitamin D
1
2016
348
0.110
 Why?
Overnutrition
1
2012
37
0.110
 Why?
RNA, Messenger
4
2016
2420
0.110
 Why?
Aminosalicylic Acids
1
2012
7
0.110
 Why?
DNA, Neoplasm
6
2005
146
0.110
 Why?
Benzenesulfonates
1
2012
20
0.110
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
193
0.110
 Why?
Gene Expression Profiling
2
2016
1460
0.110
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
1992
43
0.110
 Why?
Chromones
1
2011
35
0.110
 Why?
Dasatinib
1
2011
44
0.110
 Why?
Genital Diseases, Female
1
1991
27
0.100
 Why?
Mitosis
3
2001
133
0.100
 Why?
Fluoxymesterone
1
1991
3
0.100
 Why?
Cohort Studies
2
2020
4802
0.100
 Why?
Proportional Hazards Models
4
2005
1097
0.100
 Why?
Apoptosis Regulatory Proteins
1
2012
158
0.100
 Why?
S Phase
2
2010
61
0.100
 Why?
Thiazoles
1
2011
109
0.100
 Why?
Morpholines
1
2011
99
0.100
 Why?
Reagent Kits, Diagnostic
1
1991
42
0.100
 Why?
Genital Neoplasms, Female
1
1991
62
0.100
 Why?
Flow Cytometry
3
2007
850
0.100
 Why?
Weight Gain
3
2022
488
0.100
 Why?
Neoplasm Metastasis
5
2005
562
0.100
 Why?
Chromosomes, Human, Pair 17
3
2002
58
0.100
 Why?
Proto-Oncogenes
1
1989
27
0.090
 Why?
Antibiotics, Antineoplastic
2
2009
106
0.090
 Why?
Radioisotopes
1
1989
28
0.090
 Why?
Aged
12
2015
19244
0.090
 Why?
Adult
15
2021
29923
0.090
 Why?
Dose-Response Relationship, Drug
2
2008
1930
0.090
 Why?
Anthracyclines
1
2009
38
0.090
 Why?
DNA Topoisomerases, Type II
1
2009
43
0.090
 Why?
DNA-Binding Proteins
2
2009
1168
0.090
 Why?
Treatment Outcome
5
2007
8988
0.090
 Why?
Gene Deletion
2
2002
291
0.080
 Why?
Mutation
3
1995
2977
0.080
 Why?
Pyrimidines
1
2011
372
0.080
 Why?
Epithelial Cells
1
2014
882
0.080
 Why?
MAP Kinase Signaling System
1
2010
273
0.080
 Why?
AMP-Activated Protein Kinases
1
2009
168
0.080
 Why?
RNA, Small Interfering
2
2007
531
0.080
 Why?
Protein Structure, Tertiary
1
2009
653
0.080
 Why?
Transcription Factors
2
2008
1319
0.080
 Why?
Mice, Nude
1
2009
614
0.080
 Why?
Gene Dosage
1
2008
136
0.080
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
921
0.080
 Why?
Immunoenzyme Techniques
3
1999
189
0.080
 Why?
Time Factors
4
2015
6376
0.080
 Why?
Energy Metabolism
1
2012
853
0.070
 Why?
Proto-Oncogene Proteins c-akt
3
2016
408
0.070
 Why?
Enzyme Precursors
1
2006
13
0.070
 Why?
Mitochondria
3
2008
724
0.070
 Why?
Epigenesis, Genetic
1
2010
483
0.070
 Why?
Receptor, Notch1
1
2006
63
0.070
 Why?
Herpesvirus 1, Human
1
2006
58
0.070
 Why?
Multigene Family
2
2003
167
0.070
 Why?
Lamin Type B
1
2005
6
0.070
 Why?
Herpes Simplex
1
2006
81
0.070
 Why?
Tumor Microenvironment
2
2018
386
0.070
 Why?
Age Factors
3
2003
2922
0.070
 Why?
Cell Nucleolus
1
2005
17
0.070
 Why?
Nitriles
2
2017
158
0.070
 Why?
Benzamides
2
2017
171
0.070
 Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2007
106
0.070
 Why?
Protein Kinases
1
2006
227
0.070
 Why?
Follow-Up Studies
4
2007
4461
0.070
 Why?
Feedback
1
2005
138
0.070
 Why?
Aged, 80 and over
4
2000
6464
0.060
 Why?
RNA Interference
3
2015
432
0.060
 Why?
Tacrolimus Binding Protein 1A
1
2003
5
0.060
 Why?
Tacrolimus Binding Proteins
1
2003
14
0.060
 Why?
Predictive Value of Tests
4
2011
1767
0.060
 Why?
Rats, Wistar
2
2017
358
0.060
 Why?
Mice, Inbred Strains
1
2004
294
0.060
 Why?
Estrogens, Non-Steroidal
1
2003
4
0.060
 Why?
Genes, Tumor Suppressor
1
2003
69
0.060
 Why?
Adipose Tissue
2
2018
612
0.060
 Why?
Lymph Node Excision
2
2021
111
0.060
 Why?
Phytoestrogens
1
2003
15
0.060
 Why?
Plant Preparations
1
2003
20
0.060
 Why?
Cell Line
2
2003
2310
0.060
 Why?
Estrogen Antagonists
1
2003
37
0.060
 Why?
Actins
1
2005
344
0.060
 Why?
Chromosome Banding
1
2002
18
0.060
 Why?
Anticarcinogenic Agents
1
2003
73
0.060
 Why?
Chromosomes, Human, Pair 16
1
2002
28
0.060
 Why?
Mammary Glands, Animal
1
2003
133
0.060
 Why?
Rodentia
1
2022
46
0.060
 Why?
Transfection
3
2015
780
0.060
 Why?
3' Untranslated Regions
2
2014
138
0.060
 Why?
Trefoil Factor-1
2
1992
2
0.050
 Why?
Nuclear Proteins
2
2000
536
0.050
 Why?
alpha-Fetoproteins
1
2021
33
0.050
 Why?
Fallopian Tubes
2
1991
23
0.050
 Why?
In Situ Nick-End Labeling
1
2001
124
0.050
 Why?
Sweden
1
2021
44
0.050
 Why?
Chorionic Gonadotropin
1
2021
79
0.050
 Why?
RNA, Catalytic
1
2002
157
0.050
 Why?
Plasmids
1
2002
306
0.050
 Why?
Neoplasm, Residual
1
2021
82
0.050
 Why?
RNA Stability
1
2021
75
0.050
 Why?
Antigens, Nuclear
1
2000
16
0.050
 Why?
Breast Diseases
1
2000
16
0.050
 Why?
Enhancer Elements, Genetic
1
2000
124
0.050
 Why?
Reproducibility of Results
2
2021
2713
0.050
 Why?
Telomerase
1
2001
177
0.050
 Why?
Integrin beta3
2
2013
10
0.050
 Why?
Tumor Suppressor Proteins
2
1992
261
0.050
 Why?
Trans-Activators
1
2000
270
0.040
 Why?
N-Glycosyl Hydrolases
1
1998
6
0.040
 Why?
DNA Glycosylases
1
1998
6
0.040
 Why?
Methylnitrosourea
1
2018
6
0.040
 Why?
Retrospective Studies
4
2005
11697
0.040
 Why?
Loss of Function Mutation
1
2018
34
0.040
 Why?
G2 Phase Cell Cycle Checkpoints
1
2018
41
0.040
 Why?
Case-Control Studies
2
2023
2989
0.040
 Why?
Antibodies
1
2000
333
0.040
 Why?
NF-kappa B
1
2002
630
0.040
 Why?
Codon
3
1993
80
0.040
 Why?
Half-Life
1
2018
138
0.040
 Why?
Stromal Cells
1
2018
91
0.040
 Why?
Hyaluronan Receptors
1
1998
76
0.040
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
136
0.040
 Why?
Organic Cation Transporter 2
1
2017
9
0.040
 Why?
Gene Expression
3
2013
1365
0.040
 Why?
Antigens, CD
2
2014
377
0.040
 Why?
Extracellular Matrix Proteins
1
1998
115
0.040
 Why?
DNA Repair
1
1998
178
0.040
 Why?
Steroids
1
2017
148
0.040
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2016
11
0.040
 Why?
RNA
1
2001
648
0.040
 Why?
Chromatography, Liquid
1
2017
317
0.040
 Why?
Phosphatidylinositol 3-Kinase
1
2015
21
0.030
 Why?
Oncogenes
1
2016
116
0.030
 Why?
Survival Rate
3
1998
1657
0.030
 Why?
Oncogene Proteins
1
1995
48
0.030
 Why?
Cell Nucleus
3
2006
510
0.030
 Why?
Homeodomain Proteins
1
2018
415
0.030
 Why?
Mass Spectrometry
1
2017
568
0.030
 Why?
Testosterone
1
2017
320
0.030
 Why?
Tosyl Compounds
1
2014
17
0.030
 Why?
Integrin alpha6
1
2013
7
0.030
 Why?
Antigens, Differentiation, Myelomonocytic
1
2014
43
0.030
 Why?
Leukocyte Common Antigens
1
2014
66
0.030
 Why?
Mammary Glands, Human
1
2014
65
0.030
 Why?
Analysis of Variance
2
2014
1335
0.030
 Why?
Neoplasms
2
2012
2055
0.030
 Why?
Gene Expression Regulation, Enzymologic
1
2015
269
0.030
 Why?
Parity
1
2014
99
0.030
 Why?
Brain Neoplasms
2
1993
982
0.030
 Why?
Immunoassay
1
1994
91
0.030
 Why?
Sirolimus
2
2006
190
0.030
 Why?
Premenopause
1
2014
117
0.030
 Why?
Anilides
1
2014
72
0.030
 Why?
Transplantation, Heterologous
1
2014
185
0.030
 Why?
Interleukin-6
1
2017
637
0.030
 Why?
bcl-2-Associated X Protein
2
2007
35
0.030
 Why?
Neovascularization, Pathologic
1
1995
271
0.030
 Why?
Neoplasm Transplantation
1
2014
217
0.030
 Why?
Organ Specificity
1
2013
239
0.030
 Why?
Inhibitor of Apoptosis Proteins
1
2013
43
0.030
 Why?
Immune System
1
2014
151
0.030
 Why?
Young Adult
2
2021
10138
0.030
 Why?
Lactation
1
2014
176
0.030
 Why?
Lipogenesis
1
2012
70
0.030
 Why?
Point Mutation
1
1993
200
0.030
 Why?
Astrocytoma
1
1993
107
0.030
 Why?
Molecular Targeted Therapy
1
2015
359
0.030
 Why?
Broad Ligament
1
1991
2
0.030
 Why?
Tumor Necrosis Factor-alpha
2
2007
1070
0.030
 Why?
Gene Knockdown Techniques
1
2013
295
0.030
 Why?
Peritoneum
1
1991
30
0.030
 Why?
Glycolysis
1
2012
228
0.030
 Why?
Mucins
1
1991
60
0.030
 Why?
Pilot Projects
1
2015
1320
0.030
 Why?
Pregnancy Complications, Neoplastic
1
1991
49
0.030
 Why?
Pregnancy
2
2014
5275
0.030
 Why?
Blotting, Northern
1
2010
172
0.030
 Why?
Evaluation Studies as Topic
1
1991
193
0.020
 Why?
Hormones
1
1991
129
0.020
 Why?
Soft Tissue Neoplasms
1
1991
80
0.020
 Why?
Cells, Cultured
2
2013
3582
0.020
 Why?
Glioblastoma
1
1993
256
0.020
 Why?
In Situ Hybridization
1
2010
304
0.020
 Why?
Precipitin Tests
1
1989
73
0.020
 Why?
Prospective Studies
1
2021
5949
0.020
 Why?
Risk Factors
1
2003
8453
0.020
 Why?
Radionuclide Imaging
1
1989
125
0.020
 Why?
Odds Ratio
1
1992
954
0.020
 Why?
Protein Multimerization
1
2010
141
0.020
 Why?
Lymph Nodes
1
1991
309
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
683
0.020
 Why?
Drug Interactions
1
2009
354
0.020
 Why?
Membrane Potential, Mitochondrial
1
2007
49
0.020
 Why?
Apoptotic Protease-Activating Factor 1
1
2007
2
0.020
 Why?
Cytochromes c
1
2007
64
0.020
 Why?
Amino Acid Sequence
3
1998
1579
0.020
 Why?
Biomarkers
1
2017
3342
0.020
 Why?
Male
3
2023
55563
0.020
 Why?
Caspase 10
1
2006
5
0.020
 Why?
Aging
2
2002
1553
0.020
 Why?
Caspase 2
1
2006
14
0.020
 Why?
Caspase 8
1
2006
47
0.020
 Why?
Caspase 9
1
2006
47
0.020
 Why?
Cysteine Endopeptidases
1
2006
51
0.020
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2006
11
0.020
 Why?
Caspase 7
1
2006
22
0.020
 Why?
Eukaryotic Initiation Factor-4E
1
2006
25
0.020
 Why?
Vero Cells
1
2006
51
0.020
 Why?
Cytosol
1
2006
193
0.020
 Why?
Isoenzymes
1
2007
284
0.020
 Why?
Promoter Regions, Genetic
1
2010
991
0.020
 Why?
Antineoplastic Agents, Phytogenic
1
2007
182
0.020
 Why?
Base Sequence
2
2003
1672
0.020
 Why?
Virus Assembly
1
2006
77
0.020
 Why?
Adolescent
2
2021
17117
0.020
 Why?
Protein Binding
1
2010
1568
0.020
 Why?
Taxoids
1
2004
94
0.020
 Why?
Mice, Inbred C57BL
2
2003
4136
0.020
 Why?
Protein Processing, Post-Translational
1
2006
350
0.020
 Why?
DNA, Complementary
1
2003
233
0.010
 Why?
Melanoma, Experimental
1
2003
86
0.010
 Why?
Cell Adhesion
1
2003
385
0.010
 Why?
Platelet Membrane Glycoproteins
1
2002
38
0.010
 Why?
Exons
2
1993
278
0.010
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2002
54
0.010
 Why?
Gene Targeting
1
2002
57
0.010
 Why?
Templates, Genetic
1
2001
26
0.010
 Why?
Molecular Sequence Data
2
1998
2292
0.010
 Why?
Substrate Specificity
1
2002
284
0.010
 Why?
Mice, Inbred BALB C
1
2003
847
0.010
 Why?
DNA Footprinting
1
2000
19
0.010
 Why?
DNA, Superhelical
1
2000
9
0.010
 Why?
Genes, erbB
1
2000
2
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
91
0.010
 Why?
Ploidies
1
2000
19
0.010
 Why?
Proto-Oncogene Proteins c-ets
1
2000
49
0.010
 Why?
Macromolecular Substances
1
2000
139
0.010
 Why?
Pathology, Clinical
1
2000
33
0.010
 Why?
Gene Silencing
1
2000
159
0.010
 Why?
Multicenter Studies as Topic
1
2000
223
0.010
 Why?
Genetic Therapy
1
2000
234
0.010
 Why?
Receptors, Cell Surface
1
2000
283
0.010
 Why?
Forecasting
1
2000
370
0.010
 Why?
Binding Sites
1
2000
960
0.010
 Why?
Nucleic Acid Conformation
1
2000
501
0.010
 Why?
ras Proteins
1
1998
126
0.010
 Why?
Chromosomes, Human, Pair 13
1
1996
17
0.010
 Why?
Chromosomes, Human, Pair 3
1
1996
50
0.010
 Why?
Chromosomes, Human, Pair 11
1
1996
61
0.010
 Why?
Adenine
1
1998
198
0.010
 Why?
Immunoblotting
1
1997
281
0.010
 Why?
Heterozygote
1
1996
240
0.010
 Why?
Hyaluronic Acid
1
1998
186
0.010
 Why?
Melanoma
1
2002
577
0.010
 Why?
Societies, Medical
1
2000
688
0.010
 Why?
United States
2
2004
12165
0.010
 Why?
Protein Isoforms
1
1997
315
0.010
 Why?
Transcription, Genetic
1
2000
1022
0.010
 Why?
Polymorphism, Single-Stranded Conformational
1
1995
29
0.010
 Why?
Factor VIII
1
1995
51
0.010
 Why?
Cyclin D1
1
1995
58
0.010
 Why?
Randomized Controlled Trials as Topic
1
2000
1163
0.010
 Why?
Single-Blind Method
1
1995
259
0.010
 Why?
Observer Variation
1
1995
294
0.010
 Why?
Alleles
1
1996
694
0.010
 Why?
Biopsy
1
1995
1027
0.010
 Why?
Proliferating Cell Nuclear Antigen
1
1991
53
0.010
 Why?
Peripheral Nerves
1
1991
63
0.010
 Why?
DNA
1
1996
1104
0.010
 Why?
Risk Assessment
1
2000
2976
0.010
 Why?
Protein Conformation
1
1993
636
0.010
 Why?
Polymorphism, Genetic
1
1993
576
0.010
 Why?
Lung Neoplasms
1
2002
2166
0.010
 Why?
Glioma
1
1991
289
0.000
 Why?
Cerebral Cortex
1
1991
486
0.000
 Why?
Child
1
1993
16611
0.000
 Why?
Thor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (434) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)